TetraLogic Pharmaceuticals Corporation (OTCPK: TLOG)
Health Care · Biotechnology · US
$0.00
— today · 0.0% 1Y
TetraLogic Pharmaceuticals Corporation (OTCPK: TLOG) operates in the Biotechnology industry within the Health Care sector. The company is valued at $24.00 and employs 29 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
Tweenvest scores TetraLogic Pharmaceuticals Corporation across four factors: quality 25/100, value 35/100. Its strongest factor is value.
TLOG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.65
- Dividend yield
- —
- Beta (5Y)
- -73.59
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 24.32M
- Employees
- 29
- Next earnings
- —
About TetraLogic Pharmaceuticals Corporation
TetraLogic Pharmaceuticals Corporation operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on identifying and advancing small-molecule treatments for cancer and infectious diseases. The company's development pipeline features two key clinical-stage drug candidates: birinapant and SHAPE. Birinapant, a small molecule, functions as a Second Mitochondrial Activator of Caspases (SMAC) mimetic, promoting programmed cell death, or apoptosis, in compromised cells. SHAPE, another proprietary compound, is a histone deacetylase (HDAC) inhibitor intended for topical administration to address early-stage cutaneous T-cell lymphoma. Furthermore, TetraLogic Pharmaceuticals has a research collaboration with the Walter and Eliza Hall Institute of Medical Research to explore the application of SMAC-mimetics, including birinapant, in treating infectious diseases. Founded in 2001 as Gentara Corporation, the company adopted its current name, TetraLogic Pharmaceuticals Corporation, in January 2006 and maintains its headquarters in Malvern, Pennsylvania.
- ISIN
- US88165U1097
- Founded
- 2001
- Listed since
- Dec 12, 2013
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Athersys, Inc.OTCPK: ATHX.Q | $62.00 | $0.00 | -90.00% |
| Genocea Biosciences, Inc.OTCPK: GNCA.Q | $59.00 | $0.00 | — |
| Mymetics CorporationOTCPK: MYMX | $46.00 | $— | — |
| HAVN Life Sciences Inc.OTCPK: HAVL.F | $29.00 | $— | — |
| IMV Inc.OTCPK: IMVI.F | $15.00 | $0.00 | — |
| PhaseRx, Inc.OTCPK: PZRX.Q | $12.00 | $— | — |
| ContraFect CorporationOTCPK: CFRX.Q | $11.00 | $0.00 | — |
| Notable Labs, Ltd.OTCPK: NTBL.Q | $10.00 | $— | — |
Figures last refreshed Oct 18, 2026.